Elanco Animal Health Incorporated
NYSE:ELAN
11.51 (USD) • At close February 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 352 | 345 | 638 | 494.7 | 334 | 474.8 | 323.4 | 258.8 |
| Short Term Investments
| 0 | 14 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 352 | 345 | 638 | 494.7 | 334 | 474.8 | 323.4 | 258.8 |
| Net Receivables
| 1,010 | 1,002 | 1,028 | 1,076.7 | 889.9 | 709.4 | 601.9 | 630.7 |
| Inventory
| 1,735 | 1,538 | 1,373 | 1,578.1 | 1,050.7 | 1,004.1 | 1,062.3 | 875.6 |
| Other Current Assets
| 310 | 394 | 325 | 267 | 98.5 | 316.6 | 136.1 | 182.3 |
| Total Current Assets
| 3,407 | 3,279 | 3,276 | 3,416.5 | 2,373.1 | 2,504.9 | 2,123.7 | 1,947.4 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 1,026 | 999 | 1,061 | 1,316.3 | 955.3 | 922.4 | 920.3 | 741.8 |
| Goodwill
| 5,094 | 5,993 | 6,172 | 6,224.8 | 2,989.6 | 2,958 | 2,969.2 | 2,576.5 |
| Intangible Assets
| 4,494 | 4,842 | 5,587 | 6,387.3 | 2,482.8 | 2,453 | 2,672.8 | 2,621 |
| Goodwill and Intangible Assets
| 9,588 | 10,835 | 11,759 | 12,612.1 | 5,472.4 | 5,411 | 5,642 | 5,197.5 |
| Long Term Investments
| 26 | 37 | 30 | 35.7 | 21.1 | 15.3 | 12.3 | 9 |
| Tax Assets
| 0 | -37 | -30 | -35.7 | -21.1 | 0 | 0 | 0 |
| Other Non-Current Assets
| 315 | 378 | 387 | 347.8 | 185 | 103.1 | 242 | 204 |
| Total Non-Current Assets
| 10,955 | 12,212 | 13,207 | 14,276.2 | 6,612.7 | 6,451.8 | 6,816.6 | 6,152.3 |
| Total Assets
| 14,362 | 15,491 | 16,483 | 17,692.7 | 8,985.8 | 8,956.7 | 8,940.3 | 8,099.7 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 270 | 390 | 416 | 501 | 222.6 | 205.2 | 203.8 | 228.2 |
| Short Term Debt
| 38 | 388 | 328 | 591.5 | 24.5 | 29 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 4.8 | 7.5 |
| Deferred Revenue
| 0 | 0 | 185 | 148.6 | 116 | 367.6 | 0 | 0 |
| Other Current Liabilities
| 933 | 924 | 903 | 983.8 | 571.4 | 736.5 | 424 | 383.2 |
| Total Current Liabilities
| 1,241 | 1,702 | 1,643 | 2,076.3 | 818.5 | 970.7 | 632.6 | 618.9 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 5,846 | 5,559 | 6,152 | 5,572.4 | 2,392.2 | 2,443.3 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 271 | 345.7 | 82.5 | 109.1 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 567 | 662 | 745 | 900.3 | 100.8 | 114.6 | 251.9 | 227.5 |
| Other Non-Current Liabilities
| 485 | 279 | 406 | 1,568.1 | 127.4 | 230.6 | 265 | 225.4 |
| Total Non-Current Liabilities
| 6,898 | 6,500 | 7,302 | 7,140.5 | 2,620.4 | 2,788.5 | 516.9 | 452.9 |
| Total Liabilities
| 8,139 | 8,202 | 8,945 | 9,216.8 | 3,438.9 | 3,759.2 | 1,149.5 | 1,071.8 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 8,047.4 | 7,484.8 |
| Retained Earnings
| -2,288 | -1,057 | -949 | -477.2 | 84.3 | 16.4 | 0 | 0 |
| Accumulated Other Comprehensive Income/Loss
| -266 | -392 | -209 | 303 | -173.7 | -222.2 | -256.6 | -456.9 |
| Other Total Stockholders Equity
| 8,777 | 8,738 | 8,696 | 8,650.1 | 5,636.3 | 5,403.3 | 10.5 | 0 |
| Total Shareholders Equity
| 6,223 | 7,289 | 7,538 | 8,475.9 | 5,546.9 | 5,197.5 | 7,790.8 | 7,027.9 |
| Total Equity
| 6,223 | 7,289 | 7,538 | 8,475.9 | 5,546.9 | 5,197.5 | 7,790.8 | 7,027.9 |
| Total Liabilities & Shareholders Equity
| 14,362 | 15,491 | 16,483 | 17,692.7 | 8,985.8 | 8,956.7 | 8,940.3 | 8,099.7 |